These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30448697)

  • 1. Autophagy inhibitor enhance ZnPc/BSA nanoparticle induced photodynamic therapy by suppressing PD-L1 expression in osteosarcoma immunotherapy.
    Yu W; Wang Y; Zhu J; Jin L; Liu B; Xia K; Wang J; Gao J; Liang C; Tao H
    Biomaterials; 2019 Feb; 192():128-139. PubMed ID: 30448697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy.
    Su Z; Xiao Z; Huang J; Wang Y; An Y; Xiao H; Peng Y; Pang P; Han S; Zhu K; Shuai X
    ACS Appl Mater Interfaces; 2021 Mar; 13(11):12845-12856. PubMed ID: 33709684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy.
    Xiong W; Qi L; Jiang N; Zhao Q; Chen L; Jiang X; Li Y; Zhou Z; Shen J
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):8026-8041. PubMed ID: 33577301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
    Zheng B; Ren T; Huang Y; Guo W
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Psoriasis Effects and Mechanisms of Α-(8-Quinolinoxy) Zinc Phthalocyanine-Mediated Photodynamic Therapy.
    Liu HQ; Wang YM; Li WF; Li C; Jiang ZH; Bao J; Wei JF; Jin HT; Wang AP
    Cell Physiol Biochem; 2017; 44(1):200-214. PubMed ID: 29131032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib-Conjugated Zinc Phthalocyanine Based Nanocapsule for Trimodal Therapy in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.
    Yu XN; Deng Y; Zhang GC; Liu J; Liu TT; Dong L; Zhu CF; Shen XZ; Li YH; Zhu JM
    ACS Appl Mater Interfaces; 2020 Apr; 12(15):17193-17206. PubMed ID: 32207914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of anti-PD-1/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework.
    Ge YX; Zhang TW; Zhou L; Ding W; Liang HF; Hu ZC; Chen Q; Dong J; Xue FF; Yin XF; Jiang LB
    Biomaterials; 2022 Mar; 282():121407. PubMed ID: 35217343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tumor microenvironment responsive biodegradable CaCO
    Liu Y; Pan Y; Cao W; Xia F; Liu B; Niu J; Alfranca G; Sun X; Ma L; de la Fuente JM; Song J; Ni J; Cui D
    Theranostics; 2019; 9(23):6867-6884. PubMed ID: 31660074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model.
    Lenna S; Bellotti C; Duchi S; Martella E; Columbaro M; Dozza B; Ballestri M; Guerrini A; Sotgiu G; Frisoni T; Cevolani L; Varchi G; Ferrari M; Donati DM; Lucarelli E
    J Exp Clin Cancer Res; 2020 Feb; 39(1):40. PubMed ID: 32087737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc phthalocyanine encapsulated in polymer micelles as a potent photosensitizer for the photodynamic therapy of osteosarcoma.
    Yu W; Ye M; Zhu J; Wang Y; Liang C; Tang J; Tao H; Shen Y
    Nanomedicine; 2018 Jun; 14(4):1099-1110. PubMed ID: 29462663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Affinity of Chlorin e6 to Immunoglobulin G for Intraoperative Fluorescence Image-Guided Cancer Photodynamic and Checkpoint Blockade Therapy.
    Xu J; Yu S; Wang X; Qian Y; Wu W; Zhang S; Zheng B; Wei G; Gao S; Cao Z; Fu W; Xiao Z; Lu W
    ACS Nano; 2019 Sep; 13(9):10242-10260. PubMed ID: 31397999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib inhibits doxorubicin-induced PD-L1 upregulation to improve immunosuppressive microenvironment in Osteosarcoma.
    Wang J; Hu F; Yu P; Wang J; Liu Z; Bao Q; Zhang W; Wen J
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5127-5138. PubMed ID: 36348018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy.
    Sundara YT; Kostine M; Cleven AH; Bovée JV; Schilham MW; Cleton-Jansen AM
    Cancer Immunol Immunother; 2017 Jan; 66(1):119-128. PubMed ID: 27853827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Osteosarcoma Immunotherapy via CaCO
    Gao Y; Wang Z; Jin X; Wang X; Tao Y; Huang S; Wang Y; Hua Y; Guo X; Xu J; Cai Z
    Adv Healthc Mater; 2024 Sep; 13(23):e2400538. PubMed ID: 38759954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse.
    Zheng B; Ren T; Huang Y; Sun K; Wang S; Bao X; Liu K; Guo W
    J Hematol Oncol; 2018 Feb; 11(1):16. PubMed ID: 29409495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of combined photodynamic and hyperthermic therapy with a new light source in an in vivo osteosarcoma tumor model.
    Nomura J; Yanase S; Matsumura Y; Nagai K; Tagawa T
    J Clin Laser Med Surg; 2004 Feb; 22(1):3-8. PubMed ID: 15117480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy.
    Wang D; Wang T; Liu J; Yu H; Jiao S; Feng B; Zhou F; Fu Y; Yin Q; Zhang P; Zhang Z; Zhou Z; Li Y
    Nano Lett; 2016 Sep; 16(9):5503-13. PubMed ID: 27525587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aloe-emodin-mediated photodynamic therapy induces autophagy and apoptosis in human osteosarcoma cell line MG‑63 through the ROS/JNK signaling pathway.
    Tu P; Huang Q; Ou Y; Du X; Li K; Tao Y; Yin H
    Oncol Rep; 2016 Jun; 35(6):3209-15. PubMed ID: 27035222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 and PD-L1 Expression in Osteosarcoma: Which Specimen to Evaluate?
    Chen S; Guenther LM; Aronhalt A; Cardillo L; Janeway KA; Church AJ
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):482-487. PubMed ID: 31842180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive nanocomposite hydrogel enhances postoperative immunotherapy and bone reconstruction for osteosarcoma treatment.
    Chu X; Mi B; Xiong Y; Wang R; Liu T; Hu L; Yan C; Zeng R; Lin J; Fu H; Liu G; Zhang K; Bian L
    Biomaterials; 2025 Jan; 312():122714. PubMed ID: 39079462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.